David L Urdal

age ~75

from Seattle, WA

Get Report
Also known as:
  • David Lloyd Urdal
  • David U Urdal
  • Dave L Urdal
  • Shirley Urdal
Phone and address:
6826 55Th Ave NE, Seattle, WA 98115
2065257940
Related to:
Connected to:

David Urdal Phones & Addresses

  • 6826 55Th Ave NE, Seattle, WA 98115 • 2065257940
  • 38 3Rd St, Los Altos, CA 94022
  • Issaquah, WA
  • Mountain View, CA
  • 6826 55Th Ave NE, Seattle, WA 98115 • 2066604751

Work

  • Position:
    Executive, Administrative, and Managerial Occupations

Education

  • Degree:
    High school graduate or higher

Emails

d***[email protected]
Name / Title
Company / Classification
Phones & Addresses
David Urdal
CTO, Vice Pres. of MIS/IS
Dendreon
Biotechnology · Medical Research and Pharmaceutical Preparations · Pharmaceutical Preparations · Research and Development in the Physical, Engineering, and L · Pharmaceutical Preparation Manufacturing · Research & Development in Biotechnology
3005 1 Ave, Seattle, WA 98121
1301 2 Ave, Seattle, WA 98101
2062564545, 2062560571, 2068291500, 2068291622
David L Urdal
IMMUNEX CORPORATION
51 University St, Seattle, WA 98101
51 Univ St, Seattle, WA
David L Urdal
Vice President
IMMUNEX OF WASHINGTON CORPORATION
Pharmaceutical Sales · Nonclassifiable Establishments · Mfg & Mktg Therapeutic Pdts & Biotherapeutic Research
51 University St, Seattle, WA 98101
1 Amgen Ctr Dr, Newbury Park, CA 91320
PO Box 19027, Newbury Park, CA 91319
300 Deschutes Way SW STE 304  , Olympia, WA 98501
2063894019, 2064704180
David L. Urdal
VLST Corp
Biotechnology · Commercial Physical Research
307 Westlake Ave N SUITE 300, Seattle, WA 98109
2062688550, 2062625544

Us Patents

  • Antibodies To Interleukin-1 Receptors

    view source
  • US Patent:
    6511665, Jan 28, 2003
  • Filed:
    May 30, 1995
  • Appl. No.:
    08/452775
  • Inventors:
    Steven K. Dower - Redmond WA
    Carl J. March - Winslow WA
    John E. Sims - Seattle WA
    David L. Urdal - Seattle WA
  • Assignee:
    Immunex Corporation - Seattle WA
  • International Classification:
    A61K 39395
  • US Classification:
    4241541, 4241301, 4241331, 4241391, 4241411, 4241421, 4241431, 4241441, 4241521, 4241531, 4241731, 5303871, 5303873, 5303879, 5303881, 53038815, 5303882, 53038822, 5303887, 53038873, 53038875, 435331, 435334, 4353432, 435346
  • Abstract:
    The present invention provides monoclonal antibodies and binding proteins which specifically bind to the IL-1 receptor. Also provided are methods for detecting IL-1 receptors on cells, and for detecting soluble IL-1 receptors in serum.

  • Type I Il-1 Receptors

    view source
  • US Patent:
    20040101528, May 27, 2004
  • Filed:
    Dec 3, 2002
  • Appl. No.:
    10/309512
  • Inventors:
    Steven Dower - Redmond WA, US
    Carl March - Winslow WA, US
    John Sims - Seattle WA, US
    David Urdal - Seattle WA, US
  • International Classification:
    A61K039/395
    C07K016/24
  • US Classification:
    424/145100, 530/388230
  • Abstract:
    The present invention provides monoclonal antibodies and binding proteins which specifically bind to the IL-1 receptor. Also provided are methods for detecting IL-1 receptors on cells, and for detecting soluble IL-1 receptors in serum.

  • Process For Purifying Interleukin-1 Receptors

    view source
  • US Patent:
    52965929, Mar 22, 1994
  • Filed:
    Mar 1, 1993
  • Appl. No.:
    8/024880
  • Inventors:
    Steven K. Dower - Redmond WA
    Carl J. March - Seattle WA
    John E. Sims - Seattle WA
    David L. Urdal - Seattle WA
  • Assignee:
    Immunex Corporation - Seattle WA
  • International Classification:
    C07K 320
  • US Classification:
    530413
  • Abstract:
    Mammalian Interleukin-1 receptor proteins (IL-1Rs), DNAs and expression vectors encoding mammalian IL-1Rs, and processes for producing mammalian IL-1Rs as products of cell culture, including recombinant systems, are disclosed.

  • Method Of Using Soluble Human Interleukin-1 Receptors To Suppress Immune Responses

    view source
  • US Patent:
    54928885, Feb 20, 1996
  • Filed:
    Jun 17, 1992
  • Appl. No.:
    7/904071
  • Inventors:
    Steven K. Dower - Redmond WA
    Carl J. March - Winslow WA
    John E. Sims - Seattle WA
    David L. Urdal - Seattle WA
  • Assignee:
    Immunex Corporation - Seattle WA
  • International Classification:
    A61K 3816
    C07K 14705
  • US Classification:
    514 2
  • Abstract:
    Methods of using shuIL-1Rs to suppress IL-1 mediated immune responses in a mammal.

  • Soluble Human Interleukin-1 Receptors, Compositions And Method Of Use

    view source
  • US Patent:
    RE354503, Feb 11, 1997
  • Filed:
    Jun 14, 1993
  • Appl. No.:
    8/077752
  • Inventors:
    Steven K. Dower - Redmond WA
    Carl J. March - Bainbridge Island WA
    John E. Sims - Seattle WA
    David L. Urdal - Seattle WA
  • Assignee:
    Immunex Corporation - Seattle WA
  • International Classification:
    C07K 1300
  • US Classification:
    530351
  • Abstract:
    Soluble human Interleukin-1 receptor proteins (shuIL-1Rs) and methods of using shuIL-1Rs to suppress immune or inflamatory responses in a mammal.

  • Interleukin-1 Receptors

    view source
  • US Patent:
    49686070, Nov 6, 1990
  • Filed:
    Feb 25, 1988
  • Appl. No.:
    7/160550
  • Inventors:
    Steven K. Dower - Redmond WA
    Carl J. March - Seattle WA
    John E. Sims - Seattle WA
    David L. Urdal - Seattle WA
  • Assignee:
    Immunex Corporation - Seattle WA
  • International Classification:
    C12N 1500
    C12N 1512
    C12N 1211
    C12N 06
  • US Classification:
    435 691
  • Abstract:
    Mammalian Interleukin-1 receptor proteins (IL-1Rs), DNAs and expression vectors encoding mammalian IL-1Rs, and processes for producing mammalian IL-1Rs as products of cell culture, including recombinant systems, are disclosed.

  • Soluble Interleukin-1 Receptors

    view source
  • US Patent:
    53190718, Jun 7, 1994
  • Filed:
    Jan 14, 1992
  • Appl. No.:
    7/821716
  • Inventors:
    Steven K. Dower - Redmond WA
    Carl J. March - Winslow WA
    John Sims - Seattle WA
    David L. Urdal - Seattle WA
  • Assignee:
    Immunex Corporation - Seattle WA
  • International Classification:
    C07K 1300
    A61K 3702
  • US Classification:
    530350
  • Abstract:
    Substantially purified and homogeneous soluble human interleukin-1 receptor (shuIL-1R) proteins, DNA encoding the shuIL-1R proteins and pharmaceutical compositions containing the shuIL-1R proteins are described.

  • Interleukin-1 Receptors

    view source
  • US Patent:
    50812289, Jan 14, 1992
  • Filed:
    Oct 13, 1988
  • Appl. No.:
    7/258756
  • Inventors:
    Steven K. Dower - Redmond WA
    Carl J. March - Seattle WA
    John E. Sims - Seattle WA
    David L. Urdal - Seattle WA
  • Assignee:
    Immunex Corporation - Seattle WA
  • International Classification:
    C07K 1300
    A61K 3702
  • US Classification:
    530 351
  • Abstract:
    Mammalian Interleukin-1 receptor proteins (IL-1Rs), DNAs and expression vectors encoding mammalian IL-1Rs, and processes for producing mammalian IL-1Rs as products of cell culture, including recombinant systems, are disclosed.

Youtube

PILOT: Cancer Immunotherapy (BioBusiness.TV O...

PILOT: Cancer Immunotherapy (BioBusiness.TV Origin...

This pilot was produced with the financial support of Celldex Therapeu...

  • Category:
    News & Politics
  • Uploaded:
    14 Jan, 2011
  • Duration:
    10m 22s
Get Report for David L Urdal from Seattle, WA, age ~75
Control profile